Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,724 | -30,910 | -28,082 | -19,942 | -8,954 |
| Depreciation Amortization | 492 | 1,963 | 1,471 | 979 | 489 |
| Accounts payable and accrued liabilities | -1,046 | -235 | 369 | -153 | 1,180 |
| Other Working Capital | -958 | -1,148 | 397 | -431 | 994 |
| Other Operating Activity | 874 | 2,560 | 4,938 | 4,046 | -1,197 |
| Operating Cash Flow | $-6,362 | $-27,770 | $-20,907 | $-15,501 | $-7,488 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -22 | -9 | -4 | -4 |
| Investing Cash Flow | $N/A | $-22 | $-9 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,048 | N/A | 0 | 0 | 0 |
| Other Financing Activity | -16 | -128 | -123 | -123 | -125 |
| Financing Cash Flow | $14,032 | $-128 | $-123 | $-123 | $-125 |
| Beginning Cash Position | 21,304 | 49,224 | 49,224 | 49,224 | 49,224 |
| End Cash Position | 28,974 | 21,304 | 28,185 | 33,596 | 41,607 |
| Net Cash Flow | $7,670 | $-27,920 | $-21,039 | $-15,628 | $-7,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,362 | -27,770 | -20,907 | -15,501 | -7,488 |
| Capital Expenditure | N/A | -22 | -9 | -4 | -4 |
| Free Cash Flow | -6,362 | -27,792 | -20,916 | -15,505 | -7,492 |